Investment Analysts’ Weekly Ratings Updates for Revvity (RVTY)

Revvity (NYSE: RVTY) has recently received a number of price target changes and ratings updates:

• 2/3/2025 – Revvity had its price target raised by analysts at Barclays PLC from $135.00 to $140.00. They now have an “overweight” rating on the stock.
• 2/3/2025 – Revvity had its price target raised by analysts at KeyCorp from $132.00 to $145.00. They now have an “overweight” rating on the stock.
• 2/3/2025 – Revvity had its “outperform” rating reaffirmed by analysts at Raymond James. They now have a $145.00 price target on the stock, up previously from $140.00.
• 1/21/2025 – Revvity had its price target lowered by analysts at Raymond James from $146.00 to $140.00. They now have an “outperform” rating on the stock.
• 1/10/2025 – Revvity was downgraded by analysts at Sanford C. Bernstein from an “outperform” rating to a “market perform” rating. They now have a $130.00 price target on the stock.
• 12/13/2024 – Revvity was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $138.00 price target on the stock.

Revvity Price Performance

Shares of RVTY stock traded down $2.21 during trading hours on Friday, hitting $116.95. 317,425 shares of the company’s stock were exchanged, compared to its average volume of 878,934. The company has a market capitalization of $14.23 billion, a PE ratio of 52.92, a PEG ratio of 4.17 and a beta of 1.03. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50. The business’s 50 day simple moving average is $117.41 and its 200-day simple moving average is $119.03. The company has a current ratio of 3.60, a quick ratio of 3.03 and a debt-to-equity ratio of 0.41.

Revvity (NYSE:RVTY) last posted its quarterly earnings results on Friday, January 31st. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same quarter in the prior year, the firm earned $1.25 EPS. On average, equities research analysts anticipate that Revvity, Inc. will post 4.97 earnings per share for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Friday, April 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.24%. The ex-dividend date of this dividend is Thursday, April 17th. Revvity’s dividend payout ratio is 12.67%.

Insider Transactions at Revvity

In related news, insider Tajinder S. Vohra sold 5,492 shares of Revvity stock in a transaction on Tuesday, January 7th. The shares were sold at an average price of $116.81, for a total value of $641,520.52. Following the sale, the insider now owns 19,652 shares in the company, valued at $2,295,550.12. The trade was a 21.84 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Joel S. Goldberg sold 15,170 shares of Revvity stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the completion of the sale, the insider now owns 33,400 shares in the company, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.60% of the company’s stock.

Institutional Trading of Revvity

Several large investors have recently added to or reduced their stakes in the stock. Empirical Finance LLC boosted its holdings in Revvity by 2.0% in the third quarter. Empirical Finance LLC now owns 4,237 shares of the company’s stock valued at $541,000 after acquiring an additional 85 shares in the last quarter. CX Institutional boosted its holdings in shares of Revvity by 1.1% during the 3rd quarter. CX Institutional now owns 7,984 shares of the company’s stock valued at $1,020,000 after buying an additional 86 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Revvity by 2.4% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 4,214 shares of the company’s stock valued at $470,000 after buying an additional 100 shares in the last quarter. HB Wealth Management LLC boosted its holdings in shares of Revvity by 4.6% during the 4th quarter. HB Wealth Management LLC now owns 2,380 shares of the company’s stock valued at $266,000 after buying an additional 104 shares in the last quarter. Finally, Westside Investment Management Inc. boosted its holdings in shares of Revvity by 0.8% during the 4th quarter. Westside Investment Management Inc. now owns 14,363 shares of the company’s stock valued at $1,603,000 after buying an additional 108 shares in the last quarter. Institutional investors own 86.65% of the company’s stock.

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.